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Summary: In high perfonnance liquid Chromatographie procedures hitherto described, SiO2, NH2 and RP
columns have been used for the analysis of disaccharides produced by
 %the digestion of glycosaminoglycans
with the chondroitin sulphate lyases AC and ABC. The use of a potent anion exchanger offers the following
advantages over these columns: superior Separation chäracteristics for non-sulphated disaccharides, and
improved column perfonnance, coupled with more stable analytical conditions. Elution with dilute saline
Solutions permits Separation of the two non-sulphated disaccharides from chondroitin and hyaluronate.
The sequential application of chondroitinase AC and ABC permits the determination of hyaluronate, the
chondroitin sulphate isomers and the dermatan sulphate isomers by high perfonnance liquid Chromatographie
Separation of the products of enzymatic hydrolysis. In a previously described method, hyaluronate lyase was
used for the determination of hyaluronate. It has been found, however, that omission of the hyaluronate
lyase step results in superior accuracy in the high performance liquid Chromatographie Separation of the non-
sulphated disaccharides.
The enzymatic analysis of human articular cartilage glycosaminoglycans has repeatedly yielded a fraction
which is not digestable by chondroitinase AC, but is completely digestable by chondroitinase ABC. More
extensive characterization has disclosed that this fraction differs structurally from chondroitin sulphate.
Enzymatic characterization indicates that it should presumably be assigned to dermatan sulphate.
Hochleistungsflüssigkeitschromatographische Bestimmung von Di- und Oligosacchariden aus dem Abbau von
Glykosaminoglykanen mit Chondroitinsulfatlyasen
ZusaHunenfassung: Bei den bisher beschriebenen hochleistungsflüssigkeitschromatographischen Verfahren zur
Analyse von Disacchariden aus dem Abbau von Glykosaminoglykanen mit den Chondroitinsulfatlyasen AC
und ABC wurden SiO2-, NHk- und RP-Säulen verwendet. Gegenüber diesen Säulen bietet die Verwendung
eines starken Anionenaustauschers folgende Vorteile: bessere Trenneigenschaften im Bereich der unsulfatierten
Disaccharide und höhere Laufleistung pro Säulenfällung bei stabileren Analysenbedingungen. Die Elution
mit verdünnten Kochsalzlösungen ermöglicht die Trennung der beiden unsulfatierten Disaccharide aus
Chondroitin und Hyaluronat.
Durch die sequentielle Anwendung von Chondroitinase AC und ABC können durch hochleistungsflüssigkeits-
chromatographische Trennung der Metabolite Hyaluronat, die Chondroitinsulfatisomere sowie die
Dermatansulfatisomere bestimmt werden. Verglichen mit einer früher beschriebenen Methode, bei der zur
Hyaluronatbestimmung Hyaluronatlyase verwendet wurde, zeigt sich, daß ohne den Hyaluronatlyase-Schritt
durch hochleistungsflüssigkeitschromatographische Trennung der unsulfatierten Disaccharide eine bessere
Richtigkeit erreicht wird.
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Bei der enzymatischen Analyse von humanen Gelenkknorpelglykosaminoglykanen wurde immer eine Fraktion
gefunden, die mit Chondroitinase AC nicht, mit Chondroitinase ABC aber vollständig abgebaut werden
konnte. Eine weitergehende Charakterisierung zeigte, daß sie sich strukturell von Chondroitinsulfat unter-
schied. Aufgrund der enzymatischen Charakterisierung ist eine Zuordnung zum Dermaiitansulfat wahrschein-
lich.
Introduction
The specific enzymes hyaluronate lyase, chon-
droitinase AC and Chondroitinase ABC are being
used increasingly for the determination of individual
glycosaminoglycan components (1—7). These en-
zymes digest hyaluronate, chondroitin sulphate and
dermatan sulphate to form -ß-unsaturated uronic
acids. Sequential application of these enzymes in the
above order, and Separation of the metabolites from
the undigested glycosaminoglycans after each di-
gestion Step permits the determination of gly-
cosaminoglycan distribution patterns. Quantification
may then be performed by analysing the metabolites
of the digested components (6) or by determining the
concentrations of the undigested glycosaminoglycans
(5, 7). Metabolite analysis is the preferred method
because this also yields Information on the degree of
sulphation and the proportion of 4-sulphated and 6-
sulphated isomers.
Paper chromatography (8), thin-layer chroma-
tography (9) and various high performance liquid
chromatography methods (10 — 15) have been de-
scribed for the analysis of the -ß-unsaturated uronic
acids. Paper chromatography and thin-layer chro-
matography are time-consuming and relatively in-
sensitive. High performance liquid chromatography
should therefore be the method of choice'by virtue of
its speed and sensitivity.
One analytical procedure for the determination of
glycosaminoglycan distribution patterns has been re-
ported which is based on the sequential application
of hyaluronate lyase, chrondroitinase AC and chon-
droitinase ABC and high performance liquid
Chromatographie analysis of the products of de-
gradation (6). This procedure has been used to identify
glycosaminoglycan distribution patterns in various
human connective tissues. Experience has shown that
the method for the characterization of gly-
cosaminoglycans by sequential enzymatic digestiori
requires verification in two respects.
Firstly, analysis of the non-sulphated glycos-
aminoglycan components, hyaluronate and chon-
droitin, has not always proved satisfactory. This has
been due to inadequate precision in the determination
of the non-sulphated disaecharides, due to incomplete
high performance liquid Chromatographie Separation
of accompanying substances. An improved Chro-
matographie technique was to be used in an attempt
to increase the precision of the determination of these
two components.
Secondly, analysis of human hyaline cartilage by
sequential glycosaminoglycan digestion surprisingly
revealed dermatan sulphate in a concentration of
approximately l % of the glycosaminoglycans. To date
there have been no reports of dermatan sulphate äs a
component of articular cartilage. However, enzymatic
methods have not been used for the characterization
of articular cartilage glycosaminoglycans (16). It was
therefore necessary to establish whether this result
could be substantiated by further analyses or whether
the enzymatic method gave false results for dermatan
sulphate in this concentration ränge.
Material and Methods
Ghondroitinase AC (EC 4.2.2.5) and ABC (EC 4.2.2.4) were
purchased from Miles Biochemicals (Frankfurt, FRG) and
Sigma Chemie (Munich, FRG), hyaluronate lyase (EC 4.2.99.1)
from E. Merck (Darmstadt, FRG), Standard disae-
charides (2-acetamido-2-deoxy=3-O-(ß-jD-gluco-4-enepyrano-
syluronic acid)-Z)-galactose ( DiOS), 2-acetamido-2-deoxy-
3-O-(ß-£>-gluco-4^enepyranosyluronic acid)-4-Ö-sulpho-Z)-ga-
lactose ( Di4S), 2-acetamido-2-deoxy-3-O-(ß-D-gluco-4-
enepyranosyluronic aeid)-6-O-sulpho-£)-galactose ( Di6S))
from Miles Biochemicals (Frankfurt, FRG). 2-Acetamido-2-
deoxy-3-O-(ß-D-gluco-4-enepyianosyluronic acid)-/)-glucose
( DiHA) was prepared by digesting hyaluronic acid (umbilical
cord, Sigma Chemie, Munich, FRG) with hyaluronate lyase
followed by Chondroitinase AC, äs described below. The
disaecharides were isolated by precipitation of undigested ma^
terial with methanol (eightfold volume), followed by chro-
matography on Sephacryl S 200, desalting on Sephadex G 15
and freeze-drying. All other chemicals (E. Merck, Darmstadt,
FRG) were of analytical grade.
Isolation of glycosaminoglycans
The method used to isolate the glycosaminoglycans from
human intervertebral discs, articular eartilage and Dupuytren's
contracture has been described in füll elsewhere (6). Briefly, the
tissues were subjected to the following procedures: proteolysis
with papain, precipitation of non-glycosaminpglycan material
with perchloric acid at pH 1.3, dialysis against double-distilled
water, freeze-dyring, ß^elimination in 0.3 mpl/1 NaOH and
precipitation with ethanol (fivefold volume) äfter neutralization
with HC1. The resultant glycosaminoglycans were dissolved in
double-distilled water and analysed by.the uronic acid assay
method of Bitter & Muir (17).
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Determinat ion of glycosaminoglycan components
The procedure used for the analysis of glycosaminoglycan
distribution patterns was based on the digestion of the polymers
followed by the determination of the hydrolysis products by
high performance liquid chromatography. Glycosaminoglycans
corresponding to amounts of 0.5 to l μιυοΐ uronic acid were
used for each assay. The following procedures were used for
enzymatic depolymerization:
Digestion whh hyaturonate lyase
An aqueous solution (500 μΐ) of glycosaminoglycans was mixed
with 60 μΐ 0.1 mol/1 sodium acetate buffer, pH 6.0. The solution
was treated for 3 h at 60°C with 20 μΐ of a solution of
hyaluronate lyase (100 turbidity-reducing units in l ml 0.01
mol/1 sodium acetate buffer, pH 6.0) followed by a second
incubation Step with 10 μΐ enzyme solution (3 h). The resultant
oligosaccharides of hyaluronate were separated from the undig-
ested glycosaminoglycans by precipitation with sodium acetate-
saturated ethanol (3 ml) and digested into disaccharides by
chondroitinase AC, s described below.
Digestion with chondroitinase AC
An aqueous solution of glycosaminoglycans (500 μΐ) was mixed
with 200 μΐ Tris-HCl bufler (0.1 mol/1, ph8.0) and incubated
for 3h at 37 'C with 20 μΐ of a chondroitinase AC solution
(10kU/l double-distilled water), followed by a second in-
cubation with ΙΟμΙ of the chondroitinase AC solution (3h,
37 CC).
Digestion wifh chondroitinase ABC
The digestion was performed s for chondroitinase AC except
that a solution of ehondroitinase ABC (10 kU/1 double-distilled
water) was used.
Each enzymatic degradation Step was followed by Separation
of products from the undigested glycosaminoglycans by pre-
cipitating the undigested glycosaminoglycans with 3.8ml
sodium acetate-saturated ethanol (15 h, 4°C).
The residue was washed twice with \ ml ethanol (volume
fraction 0.96). The supernatants from the precipitation and the
wash procedure were pooled, evaporated to dryness (37 °C) and
dissolved in 200 μΐ double-distilled water. Aliquots of these
Solutions were analysed by high performance liquid chro-
matography. The following two combinations of enzymatic
degradation steps were used:
Method A
Digestion with hyaluronate lyase followed by chondroitinase
AC and chondroitinase ABC.
Method B
Digestion with chondroitinase AC followed by chondroitinase
ABC.
After chondroitinase ABC degradation, the undigested residue
was separated by thin-layer chromatography and keratan
sulphate and heparan sulphate were quantified by determining
hexosamine (18) and uronic acid (17) respectively, s described
in a previous publication (6).
High performance liquid chromatography
The Chromatograph comprised the following modules: 600/200
constant flow pump (Gynkotek, Munich, FRG), Rheodyne
7125 injectipn valve (Gynkotek, Munich, FRG) with a 10 μΐ
sample loop, SF 770 spectrophotometer (Kratos, Karlsruhe,
FRG), an LDC 301 printer/plotter/integrator system (Milton
Roy. Hasselroth, FRG) and Hyperchrome cohimns prepacked
with Nucleosil 5 SB (Bischof Analysentechnik, Leonberg, FRG).
The columns were protected by using 20 χ 4 mm cartridges s
precolumns, prepacked with Nucleosil 5 SB (Bischof Ana-
lysentechnik, Leonberg, FRG). The cartridges were changed
aftef every 100 nms. The injection volume was 10 μΐ. Elution was
performed with Solutions of sodium Chloride filtered through a
0.4 μιη filter (Millipore, Neu-Isenburg, FRG) and degassed
with helium. The wavelength used for detection was 230 nm.
Quantification was performed by calibration with Solutions of
the pure disaccharides (external Standard method). All analyses
were performed in duplicate. The migration of the disaccharides
was characterized by the phase capacity ratio
.., _ VR + VM
VT~
(where VR = elution volume of the disaccharides and VM =
elution volume of an unretained component).
Characterization of cartilage dermatan sulphate(fig-i)
Cartilage glycosaminoglycans
1. Hyaluronate lyase
2. Ethanol/sodium acetate
Not
analysed
Chondroitin sulphate
Dermatan sulphate
Keratan sulphate
1. Chondroitinase AC
2. Ethanol/sodium acetate
HPLC Dermatan sulphate
Keratan sulphate
HPLC
1. Chondroitinase AC
2. Ethanol/sodium acetate
1. Chondroitinase ABC
2. Ethanol/sodium acetate
HPLC"
Fig. 1. Isolation and characterization of the fraction not di-
gestablc by chondroitinase AC but digestable by chon-
droitinase.
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Pooled glycosaminoglycans from human articular cartilage (21
to 45 years old) were digested by hyaluronate lyase and
chondroitinase AC, äs described in the previous section. The
glycosaminoglycans precipitating with sodium acetate/ethanol
were ihen chromatographed on Sephadex G 50 (150 0.8 cm,
10 ml/h) using double-distilled water äs eluent. The column was
characterized by chromatography of blue dextran (void volume)
and the metabolites of chondroitinase AC-digested chondroitin
sulphate (disaccharides) and hyaluronate lyase-digested
hyaluronate (oligosaccharides). Fractions were analysed by
uronic acid determination (17), hexosamine determination (18)
and by absorption at 230 nm. Peaks containing hexa- and tetra-
saccharides were lyophilized, dissolved in double-distilled water
and digested with chondroitinase AC a second time. After
Separation from the undigested material by ethanol/sodium
acetate precipitation, the metabolites were degraded with chon-
droitinase ABC. All fractions containing metabolites were
evaporated, dissolved in double-distilled water and analysed by
high performance liquid chromatography. At each degradation
step double-distilled water was submitted to the same digestion
procedure and analysed äs a control.
Results
High performance liquid chromatography
of the disaccharides
The effect ofionic strength on the elution pattern
Nucleosil SB is a potent ion exchanger on a silica gel
basis, having a quaternary ammonium group äs its
functional group. Since an ion exchange mechanism
may be postulated for Separation, aqueous saline
Solutions were selected äs eluents. Aqueous sodium
chloride Solutions, sodium sulphate Solutions, buf-
fered sodium acetate and buffered sodium phosphate
Solutions (pH 4.5—6) were used in preliminary ex-
periments to separate a Standard solution of the
pure disaccharides. The best Separation results were
obtained with sodium chloride Solutions. All the
other Solutions yielded broad peaks which were not
sufficiently separated in the case of the sulphated
disaccharides. The addition of organic solvents
(acetonitrile, methanol, tetrahydrofuran) up to
volume fractions of 0.10 resulted in further peak
broadening and in double peaks.
The effect of the ionic strength of the eluent on the
Separation pattern was studied with sodium chloride
Solutions in the concentration ränge from 0.13 to
0.25mol/l. Chromatography was performed with a
solution containing a mixture of the three pure
disaccharides in concentrations of 120 / water.
Figure 2 shows that the phase capacity ratio k' for
the two sulphated disaccharides decreases äs the ionic
strength increases. In this ränge the phase capacity
ratio for the non-sulphated disaccharide displays only
a slight reduction äs the ionic strength increases.
Samples obtained during analysis of glycos-
aminoglycan distribution patterns by fractionated
10
^ 8
±
0.14 0.16 0.18 0.20 0.220.12
Fig. 2. Variation öf the phase capacity ratio k' with ionic
strength:
O 2-acetamido-2rdeoxy^O-(ß-/)-gluco-4-enepyrano-
syluronic acid)-Z)-galactose;
A 2racetamido-2-depxy-3-O-(ß-i>-gIucor4^enepyrano-
sylurorn'cadd^O-sulpho-D-galactose;
O 2-acetamido^2-deoxy-3-O-(ß-/)-gluco-4-enepyrano-
syluronic acid)-6-Osulpho-jD^galactose.
Flow rate: l ml/min.
enzymatic digestion (6) contaiiied a number of sub-
stances (buffer salts) with retention times similar to
those of the non-sulphated disaccharides. In particu-
laf, sodium acetate fronji the sodium acetate/ethanol
precipitation step has a retention time only slightly
longer than the non-sulphated disaccharides and can
give rise to considerable errörs due to incomplete
Separation. Complete Separation of the non-sulphated
disaccharides from the accompanying salts is achieved
with eluents with sodium chloride concentrations
below 0.2 mol/1. All Chromatographie procedures Were
therefore performed using eluents containing sodium
chloride in the concentration ränge from 0.16 to 0.18
mol/1.
Linearity and reproducibility
In order to determine the ränge of linearity, chro-
matography was perforrned using Solutions con-
taining mixtures of the pure disaccharides in con-
centrations between 10 and 4800 nmol/ml (0.1 and
48 nmol/injection). A linear increase in the signal
accompanied the increase in sample concentration for
the sulphated disaccharides ovef the entire ränge
measured (fig. 3).
For 2-acetamido*2-deoxy-3-O-(jß-Z>-gluco-4-enepy-<
ranosyluronic acid)-D-galactose, the linear ränge only
extended up to 20 nmol/injection. Samples with a
higher concentratiöri were therefdre diluted, othenvise
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Fig. 3. Linearity of detector response: peak area vs. sample
amount.
o 2-acetamido-2-deoxy-3-O-( -/3-gluco-4-enepyrano-
syluronic acid)-£>-galactose;
A 2-acetamido-2-deoxy-3-O-( -/)-gluco-4-enepyrano-
syluronic acid)-4-O-sulpho-/)-gaiactose;
O 2-acetamido-2-deoxy-3-O-( -/)-gluco-4-enepyrano-
syluronic acid)-6-O-sulpho-Z)-galactose.
Flow rate: l ml/min; eluent: 0.16mol/l NaCl; column
length: 4 χ 125 mm plus 20mm precolumn.
the results obtained would have been too low.
The correlation coefficients for the three disaccharides
were greater than 0.998, although for 2-acetamido-2-
deoxy-3-O-( -£-gluco-4-enepyranosyluronicacid)-/>-
galactose only the linear r nge up to 20nmol was
taken into account.
The coefficients of Variation within a series and from
day to day were determined in order to monitor the
reproducibility of chromatography. For this purpose
a Standard mixture of the three disaccharides
was analysed (2-acetanudo-2-deoxy-3-O-( -jD-gluco-
4-enepyranosyluronic acid)-/)-galactose: 130 μηιοΐ/ΐ;
2-acetamido-2-deoxy-3-O-( -Z)-gluco-4-enepyrano-
syluronic acid)-4-O-sulpho-/)-galactose: 124 μιηοΐ/ΐ;
2-acetamido-2-deoxy-3-O-( -£>-gluco-4-enepyrano-
syluronic acid)-6-O-sulpho-/)-galactose: 120 μπιοΐ/ΐ).
Coefficients of Variation ranging from 1.7% to 3.4%
were calculated within a series of 11 chromatograms
(tab. l, I). For the determination of the coefficient of
Variation from day to day, 8 chromatograms were
run on four consecutive days: on each of these days
a Standard solution was analysed at the beginning
and end of a series of 45 runs. The coefficients of
Variation ranged between 2.0% and 3.0% (tab. l,
II). No recalibration was carried out during this
experiment but the precolumns were changed
routinely after every 100 runs.
The following coefficients of Variation were found
for a series of 10 chromatograms for disaccharide
concentrations at the lower limit of the measuring
r nge: 2-acetamido-2~deoxy-3-O-( -Z>-gluco-4-ene-
pyranosyluronic acid)-Z)-galactose 2.9% (19.7
μπιοΙ/1); 2-acetamido-2-deoxy-3-O-( -Z>-gluco-4-ene-
pyra-nosyluronic acid)-4-O-sulpho-£>-galactose
10.4% (21.2 μιηοΐ/ΐ); and 2-acetamido-2-deoxy-3-O-
( -/)-gluco-4-enepyranosyluronic acid)-6-O-sulpho-
Z)-galactose 9.1% (18.7 μιηοΐ/ΐ).
%
Separation of the non-sulphated disaccharides
The digestion of glycosaminoglycans with chon-
droitinase AC yields two different non-sulphated
disaccharides: 2-acetamido-2-deoxy-3-O-( -Z)-gluco-
4-enepyranpsyluronic acid)-/)-galactose from the
non-sulphated regions of chondroitin sulphate and
2-acetamido-2-deoxy-3-O-( -£>-gluco-4-enepyrano-
syluronic acid)-/)-glucose from hyaluronate. These
two disaccharides may be separated by paper chro-
matography. However, since this method is extremely
time-consuming, an attempt was made to discover a
more rapid high performance liquid chromatography
method.
When the ion exchanger was used s the stationary
phase, a reduction in the ionic strength of the eluent
resulted in higher k' values. It was therefore suspected
that Separation of the two sulphated disaccharides
would be possible using highly dilute sodium chloride
Solutions s eluents. In fact, a mixture of the two
Tab. 1. Reproducibility of high performance liquid Chromatographie analysis.
I: 11 runs in series;
II: 8 runs between series without recalibration (two runs each day, one at the beginning and one at the end of a series
of 45 runs).
Coefficient of
Variation (%)
CVI
CVII
2-Acetamido-2-deoxy-
3-O-( -D-gluco-4-ene-
pyranosyluronic acid)-
Z)-galactose
1.7
3.0
2^Acetamido-2-deoxy-
3-O-( -/>-gluco-4-ene-
pyranosyluronic acid)-
4-O-sulpho-Z>-galactose
2.2
2.6
2-Acetamido-2-deoxy-
3-O-( -/)-giuco-4-ene-
pyranosyluronic acid)-
6-O-sulpho-Z>-galactose
3.4
2.0
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disaccharides begins to separate when salt con-
centrations in the eluent are below 100mmol/l.
Complete baseline Separation was obtained with 30
mmol/1 sodium Chloride (column length: 250 mm) or
15mmol/l sodium chloride (column length 125mm
-f 20 mm precolumn) (fig. 4).
Satisfactory quantitative results were obtained under
these conditions even in the presence of major
differences in concentration between the two non-
sulphated disaccharides. Moreover, the retention
times of the sulphated disaccharides were so great
that they did not disturb chromatography by causing
additional peaks or baseline drift within series of
chromatograms.
With regard to the r nge of linearity, a linear increase
in the signal was obtained s the sample concentration
increased in the r nge from 14 to 3800 μιηοΐ/ΐ (140
pmol to 38 nmol/injection) (fig. 5). An identical
straight line was found for the two non-sulphated
disaccharides. This is possibly due to the identical
absorption pattern of the two disaccharides, based
on a comparable steric arrangement of the a- -
unsaturated carboxyl groups. The coefficients of Vari-
ation within a 10 chromatogram series were 5.6%
(2-acetamido-2-deoxy-3-O-( -D-gluco-4-enepyrano-
syluronic acid)-/)-galactose; sample concentration:
2.38 nmol/injection) and 3.5% (2-acetamido-2-deoxy-
3-O-( -D-gluco-4-enepyranosyluronic acid)-/)-glu-
cose; sample concentration: 2.10 nmol/injection).
Dermatan sulphate in human hyaline ar-
ticular cartilage
• r
In the course of the sequential enzymatic digestion of
glycosaminoglycans from human hyaline cartilage
(anulus fibrosus, nucleus pulposus), a fraction was
detected which was not digestable by chondfoitinase
AC but was digestable by chondroitinase ABC and
therefore had to be designated s dermatan sulphate.
Since this glycosaminoglycan component had not
previously been detected in this tissue, it became
necessary to verify the correctness of the enzymatic
dermatan sulphate determination by further char-
acterization of this fraction. For this purpose,
hyaluronate was digested with hyal ronate lyase, then
chondroitin sulphate was digested with chon-
droitinase AC in pooled glycosaminoglycans from
human articular cartilage (fig. 1). The metabolites
were separated from the undigested glycos-
aminoglycans by precipitation with ethanol/sodium
acetate. In addition to keratan sulphate, the pre-
cipitate would have to contain the fraction which
is digestable by chondroitinase ABC but not by
chondroitinase AC. Chromatography of the pre-
cipitate on Sephadex G 50 revealed four fractions.
Reference Dupuytren's
controcture
Hyaline cartiloge
0.010 - AOiOS
ε
c
s
0.005 -
ΔΟΙΗΑ
AOiOS
ΔΟΪΗΑ
0 8 16 24 0 8 16 24
t i m i n ) t [min ) 0 8 16 24t imin )
Fig. 4. Separation of non-sulphated disaccharides derived
from chondroitin (2-acetamido-2-deoxy-3-O-( -D-ghi-
co-4-enepyranosyluronic acid)-D-galactose, Δ DiOS)
and hyaluronate (2-acetamido-2-deoxy-3-O-( -£>-
gluco-4-enepyranosyhironic acid)-D-glucose, Δ DiHA).
Reference disaccharide concentrations: ADiOS' 233
μπιοΐ/l; Δ DiHA: 203 μτηοΐ/ΐ.
Total glycosaminoglycans were isolated from · Du-
puytrerfs contracture and human articular cartilage.
Conditions of chromatography: column lenghf 4 χ
250 mm; eluent: 0.025 mol/1 NaCl; flow rate: 0 8 ml/
min. '
0.1880.3750.7501.50 3.00 6.00 12.0 24.0 48.0
cdisacchoride (nmol/injection v lume]
Fig. 5. Linearity of detector response: peak area vs. sample
amount.
e 2-acetamido-2-deoxy-3-O-( -/)-gluco^47enepyrano-
syluronic acid)-D-galactose;
O 2-acetamido-2-deoxy^3-iO-( ^/)-gl co^enepyranOT
syluronic acid)-D*glucose.
. Flow rate: 0.8 ml/min; eluent: 0.025 mol/1 NaCl; column
length: 4 χ 250 mm.
J. Clin. Chem. Clin·. Biochem. / Vol. 23, 1985 / No. 2
Gurr et al.: HPLC assay of disaccharides and oligosaccharides 83
The fraction in the void volume contained hexosamine
and no detectable quantities of uronic acids. This was
therefore assigned to keratan sulphate. Uronic acids
were detected by the carbazol assay in the remaining
three fractions (17). In addition, like oc-ß-unsaturated
uronic acids, these displayed absorption at 230 nm.
Following oligosaccharide chromatography, these
three fractions were characterized äs disaccharides,
tetrasaccharides and hexasaccharides on the basis of
their retention times.
Repeat incubation of the isolated tetra- and
hexasaccharides with chondroitinase AC did not re-
sult in further cleavage of the oligomers. This demon-
strated that the oligosaccharides are not susceptible
to further digestion by chondroitinase AC. The activ-
ities of the enzyme Solutions were verified in parallel
experiments with pure chondroitin sulphates, and the
absence of disaccharides in the test mixture was
established with the aid of glycosaminoglycan-free
blank values.
A substance which could be precipitated with ethanol/
sodium acetate could no longer be detected following
incubation of the tetrasaccharides and the
hexasaccharides with chondroitinase ABC. Disac-
charides were obtained whose sulphation pattern
differed from that of the chondroitin sulphate of this
glycosaminoglycan preparation: the sulphate group
was located predominantly at the C4 atom of the
galactosamine. The ratio of C6 and C4 isomers was
therefore far lower with the tetrasaccharides and
the hexasaccharides than with the disaccharides of
chondroitin sulphate (disaccharides 17; tetra-
saccharides 0.25; hexasaccharides 0.16; fig. 6).
Determinat ion of glycosaminoglycan dis-
t r ibu t ion patterns
For the determination of glycosaminoglycan dis-
tribution patterns a technique has been described in
which hyaluronate, chondroitin sulphate and finally
dennatan sulphate are digested in seqüential Steps
using hyaluronate lyase, chondroitinase AC and chon-
droitinase ABC, followed by high per/ormance liquid
Chromatographie analysis of the metabolites (6). The
undigested components heparan sulphate and keratan
sulphate are separated by thin-layer chromatography
and quantified by assaying hexosamine and uronic
acid respectively. High performance liquid Chro-
matographie Separation of the non-sulphated di-
saccharides from hyaluronate and chondroitin should
now permit the determination of these two gly-
cosaminoglycan compoiients directly without the use
of hyaluronate lyase. Firstly, the completeness of
Chondroitinase AC:
Chondroitin sulfate
Chondroitinase ABC:
Tetrosaccharides
Chondroitinase ABC:
Hexasaccharides
0.010
§
g
0.005
AOitS
0 4 8 12 0 4 8 12 16 20 0 4 8 12 16 20
t imin] t imin) t im in ]
Fig. 6. High performance liquid chromatography of di-
saccharides from human cartilage glycosaminoglycans.
Chondroitin sulphate digested by chondroitinase AC.
Tetrasaccharides and hexasaccharides: fractions not di-
gestable by chondroitinase AC but digestable by chon-
droitinase ABC.
Di4S: 2-acetamido-2-deoxy-3-O-(ß-D-gluco-4-enepy-
ranosyluronic acid)-4-O-sulpho-£>-galactose;
DiS6: 2-acetamido-2-deoxy-3-O-(ß-£-gluco-4-enepy-
ranosyluronic acid)-6-O-sulpho-D-galactose.
Conditions of chromatography: column length: 4
125mm j>lus 20mm precolumn; eluent: 0.17 mol/1
NaCl; flow rate: l ml/min (chondroitin sulphate) and
0.8 ml/min (oligosaccharides).
hyahironate-chondroitin sulphate digestion by chon-
droitinase AC alone was investigated. The ex-
periments were performed using glycosaminoglycans
isolated from Dupuytren's contracture because these
samples have a relatively high hyaluronate content
(22, 23). In 5-fold determinations, digestion with
chondroitinase AC was performed in two consecutive
Steps (I, II) to measure the completeness of the
reaction. The concentration of unsaturated di-
saccharides was determined by high performance
liquid chromatography in both fractions in exactly
the same way äs for the subsequent digestion Step
with chondroitinase ABC.
The results (tab. 2) show that after the first digestion
Step with chondroitinase AC only small amounts of
chondroitin and hyaluronate (< 2%) remained in the
sample. Since the chondroitin sulphate metabolites
were detected in approximately equal amounts, this
appears to be a carry over rather than incomplete
digestion due to Inhibition of chondroiünase AC. In
support of this theory, 2-acetamido-2-deoxy-3-O-(ß-
Z)-gluco-4-enepyranolsyluronic acid)-Z)-glucose could
no longer be detected among the degradation products
of chondroitinase ABC, even though hyaluronate is
also converted to disaccharides by this enzyme, albeit
more slowly than by chondroitinase AC. Hyaluronate
is therefore completely digested by chondroitinase
AC during the first Step. The coeflficients of Variation
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Tab. 2. Determination of the compleleness of chondroitin sulphate degradation not preceded by hyaluronate lyase application
(Method B). Analysis of glycosaminoglycans isolated from Dupuytren's contracture, n = 5. Relative concentration: molar
portion of total glycosaminoglycans. Digestion with chondroitinase AC was performed twice (I and II). PI: portion
found in step 1; PII: portion found in Step II.
Glycosaminoglycan
component
Hyaluronate
Chondroitin
Chondroitin-4-sulphate
Chondroitin-6-sulphate
Non-sulphated dermatan sulphate
Dermatan-4-sulphate
Dermatan-6-sulphate
Relative
concentration
0.131
0.098
0.047
0.165
0.026
0.514
0.018
Coefficient of .
Variation (%)
8.4
5.9
13.4
6.8
10.8
2.5
10.6
PI
0.990
0.984
0.953
0.979
—
P II
o.bio
0.016
0.047
0.021
—
ranged from 2.5% (dermatan-4-sulphate) to 13.4%
(chondroitin-4-sulphate) in 5-fold determinations.
The high coefficients of Variation for chondroitin-4-
sulphate, dermatan-0-sulphate and dermatan-6-
sulphate may be attributed to their low concen-
trations. In these cases, quantities of the order of
100 pmol had to be detected by chromatography.
In a second experiment, glycosaminoglycan analysis
with the hyaluronate lyase step but without Separation
of the non-sulphated disaccharides (Method A) was
compared for consistency with glycosaminoglycan
analysis without the hyaluronate lyase step but with
Separation of the non-sulphated disaccharides
(Method B). In this experiment, glycosaminoglycans
from 4 intervertebral discs were investigated in parallel
using the two methods. Table 3 shows that the results
for all components were highly consistent. This also
applies for the non-sulphated disaccharides when
hyaluronate and chondroitin are added together.
However, lower hyaluronate and higher chondroitin
concentrations were detected with Method A than
with Method B. This finding is due to the formation
of oligomers (tetrasaccharides, hexasaccharides and
octasaccharides) from hyaluronate by hyaluronate
lyase (2). The solubility of these oligosaccharides in
ethanol/water Solutions decreases äs the proportion
of ethanol and the molecular weight increase. Con-
sequently, äs the proportion of ethanol increases
in the precipitation step following incubation with
hyaluronate lyase, increasing amounts of hyaluronate
oligosaccharides are co-precipitated with the undig-
ested glycosaminoglycans (including chondroitin).
During subsequent incubation with chondroitinase
AC, both chondroitin and the oligosaccharides are
digested to form non-sulphated disaceharides. With
Method A these non-sulphated disaccharides are
assigned collectively to chondroitin without further
differentiation by high performance liquid chro-
matography. This results in excessively high chon-
droitin conceiitrations and excessively low hyal-
uronate concentrations. Dürmg precipitation with a
5-fold volume of ethanol after the hyaluronate lyase
step, approximately 50% of hyaluronate is tfänsferred
to chondroitin (tab. 3). Following identical pre-
cipitation with a 4-fold volume of ethanol, approxi-
mately 15% of hyaluronate is transferred to chon^
droitin (results not shown here). In contrast, complete
Separation of these two components is achieved with
Method B.
Discussion
High performance liquid chromatography
Descriptions of various methods for the high per-
formance liquid Chromatographie Separation of <**ß-
unsaturated uronic acids are to be found in the
published literature. However, the majority of these
methods have proved unsatisfactory. Chromato-
graphy on silica gel columns is performed with a
ternary elution mixture of dichloromethäne, methanol
and aqueous buffer Solutions which is difficult to use
(12). The disadvantages of ion-pair chromatography
using reversed-phase columns are löng retention times
and pronounced sensitivity to minor variations in the
eluent (13). The commonest procedure involves the
use of weak anion exchangers in which primary
amines form the stationary phase (10, 11). However,
unsatisfactory results have been obtained wher*
determining non-sulphated disaccharides frOm hyal-
uronate and chondroitin beeause the Separation of
accompanying substances is incomplete. In pärticülar,
Separation of sodium acetate from the ethanol/sodium
acetate precipitation step becomes less and less
complete äs the column becomes older, with the
result that spüricmsly high välues, ^ re obtained for
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Tab. 3. Comparison of Method A and Method B: parallel analysis of human intervertebral disc glycosaminoglycans. Relative
concentration: molar portion of total glycosaminoglycans. HA: hyaluronate; Ch: chondroitin; EOS: hyaluronate plus
chondroitin; CS4, CS6: chondroitin-4-sulphate, chondroitin-6-sulphate; DS4, DS6: dermatan-4-sulphate, dermatan-6-
sulphate; KS: keratan sulphate; A,, A2, NI, N2: glycosaminoglycans isolated from anulus fibrosus (A) and nucleus
pulposus (N) respectively.
Sample Relative concentration of glycosaminoglycan components
HA Ch 08 CS4 CS6 DS4 DS6 KS
Method A (including hyaluronate lyase)
A,
A,
N,
N2
A,
A,N;
N2
0.018
0.021
0.009
0.011
Method
0.035
0.047
0.018
0.020
0.016
0.020
0.009
0.009
B (excluding
0.001
0.002
0.002
0.002
0.034
0.041
0.018
0.020
hyaluronate lyase)
0.036
0.049
0.020
0.022
0.021
0.022
0.024
0.028
0.020
0.019
0.023
0.021
0.519
0.503
0.568
0.606
0.571
0.516
0.524
0.831
0.010
0.006
0.006
0.004
0.008
0.005
0.003
0.003
0.009
0.007
0.007
0.008
0.009
0.006
0.007
0.004
0.386
0.420
0.376
0.334
0.356
0.406
0.424
0.320
chondroitin and hyaluronate. The use of a potent
anion exchanger has been reported in the literature
(14,15). However, application has been limited to 3H-
labelled disaccharides, and quantification has been
performed by fractionation and subsequent activity
determination. The precision of Separation, in par-
ticular that of non-sulphated disaccharides from non-
labelled buffer salts, has therefore not been assessed.
Comparison of chromatography on a potent anion
exchanger with quaternary ammonium functional
groups (the technique described here) and chro-
matography on amino phases reveals that similarly
good results are obtained with both methods in the
determination of the two sulphated disaccharides.
However, the potent anion exchanger gives a con-
siderably greater Separation of the non-sulphated
disaccharides, and Separation of these disaccharides
from buffer salts and other accompanying substances
is complete. Consequently, compared with chro-
matography on NHa phases, the determination of
chondroitin and hyaluronate can be performed with
greater accuracy.
In addition, 2-acetamido-2-deoxy-3-O-(ß-Z)-gluco-4-
enepyranosyluronic acid)-D-galactose and 2-acet-
amido-2-deoxy-3-O-(ß--Di-gluco-4-enepyranosyluro-
nic acid)-Z>-glucose can be separated with a con-
siderable reduction in the ionic strength of the eluent.
It is possible to achieve baseline Separation with
uniform peaks. The Separation of non-sulphated
disaccharides on amino phases at low pH values has
also been reported in the literature (24). However,
multiple peaks (probably due to imutarotation fe-
actions inside the separating columns) have been
obtained with every substance (24). While the Sep-
aration performance of the high performance liquid
chromatography method described in this paper is
comparable with that of paper chromatography, high
performance liquid chromatography is superior in
terms of speed (20 minutes —28 hours) and sensitivity
(detection limit: < l nmol-20 nmol) (19, 20).
In terms of practical use, the potent anion exchanger
was found to be superior to the amino phase.
Quantitative determination of the unsaturated di-
saccharides was dependent on the elution speed alone.
Alterations to the sodium Chloride concentration of
the eluent only resulted in changes in the retention
times and did not necessitate changes in the in-
tegration parameters within the studied concentration
ränge (0.015—0.23 mol/1 saline). Recalibration was
therefore not required, even after column change, and
regardless of the batch of stationary phase. Moreover,
the life expectancy of a column was approximately
300 to 400 runs (amino phase: approximately 200
runs). However, elution speeds in excess of l .0 ml/
min should not be used since these cause sudden
breakdown of the column matrix within 50 to 100
runs.
Accuracy of the dermatan sulphate de-
termination
It was demonstrated in a previous publication that
dermatan sulphate can be accurately determined in
a glycosaminoglycan pool by sequential enzymatic
digestion (6). In view of the unexpected detection of
small quantities of dermatan sulphate in human
hyaline cartilage, it was, however, necessary to verify
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the accuracy of the method in the analysis of cartilage
tissue (6, 21). The second incubation with chon-
droitinase AC showed that the öligosaccharides
obtained by digestion with chondroitinase AC are not
digestable by this enzyme even when isolated. It is
therefore possible to exclude both the incomplete
digestion of chondroitin sulphate by chondroitinase
AC and the partial Inhibition of chondroitinase AC
by other substances during the first incubation Step.
However, the öligosaccharides are cleaved by chon-
droitinase ABC to form disaccharides. In contrast to
chondroitinase AC, chondroitinase ABC cleaves the
bonds between galactosamine and iduronic acid. It
may therefore be assumed that iduronic acid is present
in the öligosaccharides, even though the lack of a
sufficiently sensitive assay method for such small
quantities has meant that it could not be detected.
Characterization of the fractions not digestable by
chondroitinase AC but completely digestable by chon-
droitinase ABC has revealed that the sulphation
pattern deviates markedly from that of chondroitin
sulphate: the galactosamine is sulphated pre-
dominantly at C4, with the result that the ratio of C6
and C4 isomers is about 100 times lower than with
chondroitin sulphate. Comparable differences were
also discovered during the determination of gly-
cosaminoglycan distribution patterns of intervertebral
discs (25). Dermatan sulphate is reported also to be
sulphated predominantly at the C4 atom of
galactosamine (16, 26, 27). Given the specificity of
the digesting enzymes and the high proportion of 4-
sulphated galactosamines, it may therefore be
assumed that the cartilage fraction studied here differs
from chondroitin sulphate and should presumably be
assigned to dermatan sulphate.
The occurrence of öligosaccharides following di-
gestion with chondroitinase AC suggests that this
dermatan sulphate of articular cartilage forms hybrid
molecules with chondroitin sulphate, a phenomenon
which has been reported for other tissues (27). It is
not known whether the dermatan sulphate regions
are components of a few glycosaminoglycan chains
or whether they are distributed throughout the entire
chondroitin sulphate-containing region of the pro-
teoglycans. If it is assumed that the iduronic acid
components are distributed more or less uniformly
throughout the chondroitin sulphate-containing
region, then because of their small number, they will
exert non influence on the overall physico-chemical
behaviour of these chains. This woüld explain why
dermatan sulphate has not been detected in articular
cartilage by physicochemical methods.
Chondroit in/hyaluronate determination
during glycosaminoglycan analysis
In Method A, which involves the hyaluronate lyase
step for the analysis of glycosaminoglycan distribution
patterns, hyaluronate and chondroitin are separated
by the enzymatic digestion of hyaluronate with
hyaluronate lyase, and the hyaluronate oligomers
are then separated from the chondroitin-containing
undigested glycosaminoglycans by the ethanol/
sodium acetäte precipitation step. The two
components are quantified by the high performance
liquid Chromatographie determination of the non-
sulphated disaccharides in the corresponding
fractions. The quality of the Separation of hyaluronate
oligomers and undigested glycosaminoglycans is criti-
cal for accuracy. Complete separatiou is possible by
gel chromatography (20) but this method is too
laborious for the analysis of relatively large sample
series. Separation by ethanol/sodium acetäte pre-
cipitation is simpler but has been found to be in-
complete because more and more hyaluronate
oligomers are co-precipitated äs the ethanol Content
increases.
The use of high performance liquid chromatography
to separate the non-sulphated disaccharides within
the pfevioüsly descfibed analytical procedure elim-
inates the differentiation of chondroitin and hyal-
uronate by the hyaluronate lyase step, because
2-acetamido-2-deoxy-3-O-(ß-/)-gluco-4-enepyrano-
syluronic acid)-Z)-glucose and 2-acetamido-2-deoxy-
3-O-(ß-Z>-gluco-4-enepyranosyiuronic acid)-D-galac-
tose can be determined sirmiltaneously and un-
equivocally äs degradation products of chondroitinase
AC.
The direct identification of hyaluronate and chon-
droitin äs degradation products of chondroitinase
AC is thus a major improvement in the enzymatic
characterization of glycosaminoglycans. The high
performance liquid Chromatographie Separation of
the two non-sulphäted disaccharides perinits greater
accuracy in the determination of hyaluronate and
chondroitin. Due to the elimination of the hyaluronate
lyase step from the analytical procedüre, the method
not only becomes simpler but also yields a superior
result.
Acknowiedgement
This0work was supported by the Deutsche Forschungsgemein-
schaft (SFB 54) and contains sections of the dissertätiöns by G.
Pallasch and S. Tunh.
J. Clin. Chem. Clin. Biochem. / Vol. 23, 1985 / No. 2
Gurr et al.: HPLC assay of disaccharides and oligosaccharides 87
References
1. Saito, H., Yamagata, T. & Suzuki, S. (1968) J. Biol. Chem.
243. 1536-1542.
2. Ohya, T. & Kaneko, K. (1970) Biochim. Biophys. Acta
198, 607-609.
3. Murata, K. & Bjelle, A. O. (1980) Conn. Tiss. Res. 7,
143-156.
4. Capeletti, R., Del Rosso, M. & Chiarugi, V. (1980) Anal.
Biochem. 105, 430-435.
5. Breen, M., Knepper, P.A., Weinstein, H.G., Black, L.J.,
Lewandowski, D. L. & Baltrus, B. M. (1981) Anal. Biochem.
113, 416-422.
6. Gurr, E., Schubert, R., Delbrück, A. & Koller, W. (1982)
J. Clin. Chem. Clin. Biochem. 20, 723-729.
7. Gressner, A. M., Scherer, R. R., Stuhlsatz, H. W. & Greiling,
H. (1981) J. Clin. Chem. Clin. Biochem. 19, 221 -222.
8. Yamagata, T., Saito, H., Habuchi, O. & Suzuki, S. (1968)
J. Biol. Chem. 243, 1523-1535.
9. Wassermann, L., Ber, A. & Allalouf, D. (1977) J.
Chromatogr. 136, 342-347.
10. Lee, G.J. & Tieckelmann, H. (1979) Anal. Biochem. 94,
231-236.
11. Hjerpe, A., Antonoloulos, C.A. & Engfeld, B. (1979) J.
Chromatogr. 171, 339-344.
12. Lee, G.J., Evans, J.E. & Tieckelmann, H. (1979) J.
Chromatogr. 146, 439-448.
13. Otani, N., Sato, N. & Yosizawa, Z. (1979) J. Biochem.
(Tokyo)&5, 1383-1385.
14. Delaney, S.R., Leger, M. & Conrad, H.E. (1980) Anal.
Biochem. 106, 253-261.
15. Delaney, S. R., Conrad, H. E. & Glaser, J. H. (1980) Anal.
Biochem. 108, 25-34.
16. Roden, L. (1980) In: The Biochemistry of Glycoproteins
and Proteoglycans (Lennarz, W.J., ed.) pp. 352—371.
Plenum Press, New York.
17. Bitter, A. & Muir, H. (1982) Anal. Biochem. 4, 330-334.
18. Blumenkranz, N. & Asboe-Hansen, G. (1976) Clin.
Biochem. 9, 269-274.
19. 'Murata, K. (1980) Biochem. Med. 23, 324-325.
20. Kleine, T. O. & Merten, B. (1981) Anal. Biochem. i 18,
185-190.
21. Gurr, E., Kellner, C. & Delbrück, A. VHIth meeting of
the Föderation of European Connective Tissue Societies,
Copenhagen (1982) p. 111.
22. Berger, A. & Gurr. E. Handchirurgie, in press.
23. Flint, M.H., Gillard, G.C. & Reiily, H.C. (1982) Conn.
Tiss. Res. 9, 173-179.
24. Hjerpe, A., Antonopoulos, C.A. & Engfeldt, B. (1982) J.
Chromatogr. 245, 365-368.
25. Gurr, E. & Koller, W. unpublished result.
26. Fransson, L. A. (1968) Biol. Chem. 243, 1504-1510.
27. Fransson, L. A. (1968) Archiv for Kemi 29, 95-98.
28. Stuhlsatz, H. W. & Greüing, H. (1976) In: The Methodoiogy
of Connective Tissue Research (Hall, D. A., ed.)
pp. 129-136, Joynson-Bruvvers Ltd., Oxford.%
Dr. Eberhard Gurr
Institut f. Klin. Chemie II
der Medizinischen Hochschule Hannover
Podbielskistraße 380
D-3000 Hannover 51
J. Clin. Chem. Clin, Biochem. / Vol. 23, 1985 / No. 2

